Company Filing History:
Years Active: 1999-2000
Title: Pascale Boel: Innovator in Tumor Rejection Antigens
Introduction
Pascale Boel, based in Brussels, Belgium, is a distinguished inventor known for her significant contributions in the field of cancer research. With a focus on tumor rejection antigens, her work has implications for both diagnostic and therapeutic applications, showcasing her commitment to advancing medical science.
Latest Patents
Pascale Boel holds two notable patents that reflect her innovative research. The first patent, titled "Methods for determining complexes of tumor rejection antigens," introduces a family of tumor rejection antigen precursors known as BAGE tumor rejection antigen precursors. This patent details the nucleic acid molecules that code for these antigens and highlights various diagnostic and therapeutic uses for these coding sequences and precursor molecules.
The second patent, "Isolated nucleic acid molecule encoding peptides which form complexes," further extends her research on BAGE tumor rejection antigen precursors. This patent also discusses the potential applications in diagnostics and therapeutics involving the similar nucleic acid molecules and antigen precursors.
Career Highlights
Pascale Boel is associated with the Ludwig Institute for Cancer Research Limited, where she continues her groundbreaking work in the field of oncology. Her contributions as an inventor in the realm of tumor rejection antigens not only enhance the understanding of cancer immunology but also pave the way for potential treatments.
Collaborations
Throughout her career, Pascale has collaborated with esteemed colleagues Claude Wildmann and Thierry R Boon-Falleur. These partnerships have enriched her research endeavors, combining their expertise and insights in the pursuit of advancing cancer treatment.
Conclusion
Pascale Boel exemplifies innovation in cancer research with her patents focused on tumor rejection antigens. Her work at the Ludwig Institute for Cancer Research Limited and collaborative efforts highlight the importance of teamwork in scientific discoveries. As she continues her research, Pascale's contributions are poised to make a significant impact in the fight against cancer.